Diffuse large B-cell lymphoma (DLBCL) makes up more than 30% of newly diagnosed cases of NHL. It can arise in lymph nodes or outside of the lymphatic system in the gastrointestinal tract, testes, thyroid, skin, breast, bone, or brain.
Fast-growing lymphomas such as DLBCL usually require immediate treatment. For DLBCL, RITUXAN may be given as initial treatment along with CHOP chemotherapy. CHOP stands for the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone.
RITUXAN is available by prescription only.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.